1. Home
  2. SCNI vs NUWE Comparison

SCNI vs NUWE Comparison

Compare SCNI & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.32

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Logo Nuwellis Inc.

NUWE

Nuwellis Inc.

HOLD

Current Price

$0.13

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCNI
NUWE
Founded
2003
1999
Country
Israel
United States
Employees
N/A
38
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SCNI
NUWE
Price
$0.32
$0.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
326.7K
3.4M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.14
Revenue Next Year
N/A
$18.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.12
52 Week High
$3.47
$25.95

Technical Indicators

Market Signals
Indicator
SCNI
NUWE
Relative Strength Index (RSI) 34.37 12.86
Support Level N/A $0.13
Resistance Level $0.94 $1.21
Average True Range (ATR) 0.05 0.05
MACD -0.00 -0.01
Stochastic Oscillator 10.71 1.32

Price Performance

Historical Comparison
SCNI
NUWE

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

About NUWE Nuwellis Inc.

Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: